NCT02365597 2026-06-05An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial CancerJanssen Research & Development, LLCPhase 2 Active not recruiting239 enrolled 32 charts 1 FDA
NCT04223856 2026-05-29EV-302Astellas Pharma IncPhase 3 Active not recruiting886 enrolled 12 charts 1 FDA